VYNE Therapeutics Inc. Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VYNE Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VYNE Therapeutics Inc. for January 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2018 | MNLO | Menlo Therapeutics ... | FMR LLC | Option Exercise | C | 0.00 | 821,596 | 0 | 0 | ||
| Jan 31 2018 | MNLO | Menlo Therapeutics ... | FMR LLC | Option Exercise | C | 0.00 | 2,194,357 | 0 | 0 | ||
| Jan 31 2018 | MNLO | Menlo Therapeutics ... | FMR LLC | Buy | C | 0.00 | 304,576 | 0 | 1,118,054 | 813.5 K to 1.1 M (+37.44 %) | |
| Jan 31 2018 | MNLO | Menlo Therapeutics ... | FMR LLC | Buy | C | 0.00 | 813,478 | 0 | 813,478 | 0 to 813.5 K | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Presidio Partners 2007 GP, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 21,789 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Presidio Partners 2007 GP, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 343,310 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Presidio Partners 2007 GP, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 58,777 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Presidio Partners 2007 GP, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 2,292,320 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Presidio Partners 2007 GP, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 179 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Presidio Partners 2007 GP, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 6,971 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Presidio Partners 2007 GP, L.P ... | 10% Owner | Buy | C | 0.00 | 3,263 | 0 | 61,410 | 58.1 K to 61.4 K (+5.61 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Presidio Partners 2007 GP, L.P ... | 10% Owner | Buy | C | 0.00 | 127,269 | 0 | 2,395,068 | 2.3 M to 2.4 M (+5.61 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Presidio Partners 2007 GP, L.P ... | 10% Owner | Buy | C | 0.00 | 21,789 | 0 | 58,147 | 36.4 K to 58.1 K (+59.93 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Presidio Partners 2007 GP, L.P ... | 10% Owner | Buy | C | 0.00 | 849,794 | 0 | 2,267,799 | 1.4 M to 2.3 M (+59.93 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Presidio Partners 2007 GP, L.P ... | 10% Owner | Buy | C | 0.00 | 66 | 0 | 36,358 | 36.3 K to 36.4 K (+0.18 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Presidio Partners 2007 GP, L.P ... | 10% Owner | Buy | C | 0.00 | 2,584 | 0 | 1,418,005 | 1.4 M to 1.4 M (+0.18 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Option Exercise | C | 0.00 | 3,227,700 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Buy | C | 0.00 | 1,196,552 | 0 | 1,461,552 | 265 K to 1.5 M (+451.53 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Buy | P | 17.00 | 265,000 | 4,505,000 | 265,000 | 0 to 265 K |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Remeditex Ventures LLC | 10% Owner | Option Exercise | C | 0.00 | 821,596 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Remeditex Ventures LLC | 10% Owner | Option Exercise | C | 0.00 | 2,351,097 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Remeditex Ventures LLC | 10% Owner | Option Exercise | C | 0.00 | 7,150 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Remeditex Ventures LLC | 10% Owner | Buy | C | 0.00 | 304,576 | 0 | 2,761,663 | 2.5 M to 2.8 M (+12.40 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Remeditex Ventures LLC | 10% Owner | Buy | C | 0.00 | 871,583 | 0 | 2,457,087 | 1.6 M to 2.5 M (+54.97 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Remeditex Ventures LLC | 10% Owner | Buy | C | 0.00 | 2,650 | 0 | 1,585,504 | 1.6 M to 1.6 M (+0.17 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Remeditex Ventures LLC | 10% Owner | Buy | P | 17.00 | 100,000 | 1,700,000 | 1,582,854 | 1.5 M to 1.6 M (+6.74 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 341,784 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,475,118 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 874,817 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 6,335,215 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 126,703 | 0 | 486,695 | 360 K to 486.7 K (+35.20 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 917,559 | 0 | 3,524,541 | 2.6 M to 3.5 M (+35.20 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 324,306 | 0 | 359,992 | 35.7 K to 360 K (+908.78 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 2,348,550 | 0 | 2,606,982 | 258.4 K to 2.6 M (+908.77 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 35,686 | 606,662 | 35,686 | 0 to 35.7 K |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 258,432 | 4,393,344 | 258,432 | 0 to 258.4 K |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Option Exercise | C | 0.00 | 341,784 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Option Exercise | C | 0.00 | 2,475,118 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Option Exercise | C | 0.00 | 874,817 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Option Exercise | C | 0.00 | 6,335,215 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Buy | C | 0.00 | 126,703 | 0 | 486,695 | 360 K to 486.7 K (+35.20 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Buy | C | 0.00 | 917,559 | 0 | 3,524,541 | 2.6 M to 3.5 M (+35.20 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Buy | C | 0.00 | 324,306 | 0 | 359,992 | 35.7 K to 360 K (+908.78 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Buy | C | 0.00 | 2,348,550 | 0 | 2,606,982 | 258.4 K to 2.6 M (+908.77 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Buy | P | 17.00 | 35,686 | 606,662 | 35,686 | 0 to 35.7 K |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Buy | P | 17.00 | 258,432 | 4,393,344 | 258,432 | 0 to 258.4 K |